BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 191 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q4 2019. The put-call ratio across all filers is 0.20 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $642,000 | -10.3% | 4,250 | -13.5% | 0.00% | -25.0% |
| Q2 2022 | $716,000 | -8.7% | 4,911 | -25.7% | 0.00% | +33.3% |
| Q1 2022 | $784,000 | -13.4% | 6,608 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $905,000 | +96.3% | 6,568 | -2.7% | 0.00% | +50.0% |
| Q1 2021 | $461,000 | -56.6% | 6,750 | -45.6% | 0.00% | -60.0% |
| Q4 2020 | $1,063,000 | +31.7% | 12,405 | -0.1% | 0.01% | +25.0% |
| Q3 2020 | $807,000 | -1.1% | 12,420 | +11.2% | 0.00% | 0.0% |
| Q2 2020 | $816,000 | +170.2% | 11,165 | +25.7% | 0.00% | +100.0% |
| Q1 2020 | $302,000 | -37.5% | 8,880 | 0.0% | 0.00% | 0.0% |
| Q4 2019 | $483,000 | +47.3% | 8,880 | +13.1% | 0.00% | 0.0% |
| Q3 2019 | $328,000 | – | 7,850 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |